全文获取类型
收费全文 | 885篇 |
免费 | 48篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 41篇 |
妇产科学 | 3篇 |
基础医学 | 146篇 |
口腔科学 | 8篇 |
临床医学 | 57篇 |
内科学 | 206篇 |
皮肤病学 | 19篇 |
神经病学 | 155篇 |
特种医学 | 48篇 |
外科学 | 134篇 |
综合类 | 2篇 |
预防医学 | 8篇 |
眼科学 | 15篇 |
药学 | 28篇 |
中国医学 | 2篇 |
肿瘤学 | 62篇 |
出版年
2022年 | 5篇 |
2021年 | 9篇 |
2020年 | 9篇 |
2019年 | 7篇 |
2018年 | 15篇 |
2017年 | 14篇 |
2016年 | 10篇 |
2015年 | 19篇 |
2014年 | 33篇 |
2013年 | 33篇 |
2012年 | 49篇 |
2011年 | 47篇 |
2010年 | 23篇 |
2009年 | 16篇 |
2008年 | 38篇 |
2007年 | 44篇 |
2006年 | 50篇 |
2005年 | 48篇 |
2004年 | 56篇 |
2003年 | 50篇 |
2002年 | 53篇 |
2001年 | 27篇 |
2000年 | 11篇 |
1999年 | 31篇 |
1998年 | 17篇 |
1997年 | 13篇 |
1996年 | 10篇 |
1995年 | 8篇 |
1994年 | 13篇 |
1993年 | 11篇 |
1992年 | 20篇 |
1991年 | 16篇 |
1990年 | 10篇 |
1989年 | 17篇 |
1988年 | 9篇 |
1987年 | 12篇 |
1986年 | 9篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1983年 | 3篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1979年 | 9篇 |
1978年 | 4篇 |
1976年 | 4篇 |
1975年 | 8篇 |
1969年 | 2篇 |
1968年 | 4篇 |
1967年 | 2篇 |
排序方式: 共有939条查询结果,搜索用时 31 毫秒
91.
Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia 总被引:4,自引:0,他引:4
Sakabe K Fukuda N Wakayama K Nada T Shinohara H Tamura Y 《The American journal of cardiology》2004,94(4):497-500
In this prospective study, we found beneficial short-term effects from atorvastatin therapy, including effects on low-density lipoprotein subfractions and remnant-like lipoprotein particle cholesterol, antioxidant effects, and alterations in endothelial function that may be important in early benefit from statin therapy; some effects would support much earlier benefit than previously reported. We also found long-term effects of atorvastatin, including decreased plasminogen activator inhibitor type-1 and additional significant alterations in low-density lipoprotein subfractions and endothelial function, supporting benefits from continuous long-term atorvastatin therapy beyond early reversal of hypercholesterolemia. 相似文献
92.
Hiroki Nakata Tomohiko Wakayama Takahiro Sonomura Satoru Honma Toshihisa Hatta Shoichi Iseki 《Journal of anatomy》2015,227(5):686-694
Seminiferous tubules develop from sex cords, which are embryonic structures with simple C‐shaped arches. Histologically, the epithelium of adult mouse seminiferous tubules has been divided into 12 stages based on the associations of spermatogenic cells in four cycles of spermatogenesis. However, the gross characteristics of the seminiferous tubules themselves, including their number, length, run, and mutual relationships remain largely unknown. In the present study, we analyzed all seminiferous tubules in a single adult mouse testis with high resolution using serial paraffin sections and high‐perfomance three‐dimensional reconstruction software. There were 11 seminiferous tubules with an average length of 140 mm. Each tubule ran along circular paths within the testis while making convolutions with cranial and caudal hairpin turns. The cranial turns of all tubules were in contact with the tunica albuginea, whereas the caudal turns were not, resulting in funnel‐shaped networks of these tubules with tapered caudal portions. The caudally located networks surrounded the preceding cranially located networks from the bottom and outside, similar to stacked paper cups. Five out of the 11 seminiferous tubules were continuous from one end to the other both connected with the rete testis (10 connection points). Nine branching points, one blind end, and 18 more connection points with the rete testis were detected in the remaining six seminiferous tubules, making the paths of these tubules complicated to various degrees. The present study revealed that the 3D structures of seminiferous tubules were highly regular as a whole in the adult mouse testis. 相似文献
93.
Imashuku S Teramura T Kuriyama K Kitazawa J Ito E Morimoto A Hibi S 《International journal of hematology》2002,75(2):174-177
We studied the impact of etoposide on the prognosis of 81 patients (77 of whom were children <15 years old) with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH). The study group received a median cumulative dose of 1,500 mg/m2 etoposide (range, 0-14,550 mg/m2), with a median follow-up period of 44 months (range, 20-88 months) from the diagnosis. Only 1 patient, who received 3150 mg/m2 etoposide, developed therapy-related acute myeloid leukemia (t-AML), at 31 months after diagnosis. Excluding 9 patients who underwent hemopoietic stem cell transplantation during the course of treatment, the prognosis was poorer for those patients who received less than a 1,000 mg/m2 cumulative dose of etoposide. Our results indicate that the risk of etoposide-related t-AML is low. An appropriate dosage of etoposide for the treatment of EBV-HLH would be in the range of 1,000 to 3,000 mg/m2. However, even at these doses, care must be taken to prevent the rare risk of t-AML. 相似文献
94.
Wakayama K Fukai M Yamashita K Kimura T Hirokata G Shibasaki S Fukumori D Haga S Sugawara M Suzuki T Taniguchi M Shimamura T Furukawa H Ozaki M Kamiyama T Todo S 《Transplant international》2012,25(6):696-706
Since prolonged cold preservation of the heart deteriorates the outcome of heart transplantation, a more protective preservation solution is required. We therefore developed a new solution, named Dsol, and examined whether Dsol, in comparison to UW, could better inhibit myocardial injury resulting from prolonged cold preservation. Syngeneic heterotopic heart transplantation in Lewis rats was performed after cold preservation with UW or Dsol for 24 or 36 h. In addition to graft survival, myocardial injury, ATP content, and Ca(2+) -dependent proteases activity were assessed in the 24-h preservation group. The cytosolic Ca(2+) concentration of H9c2 cardiomyocytes after 24-h cold preservation was assessed. Dsol significantly improved 7-day graft survival after 36-h preservation. After 24-h preservation, Dsol was associated with significantly faster recovery of ATP content and less activation of calpain and caspase-3 after reperfusion. Dsol diminished graft injury significantly, as revealed by the lower levels of infarction, apoptosis, serum LDH and AST release, and graft fibrosis at 7-day. Dsol significantly inhibited Ca(2+) overload during cold preservation. Dsol inhibited myocardial injury and improved graft survival by suppressing Ca(2+) overload during the preservation and the activation of Ca(2+) -dependent proteases. Dsol is therefore considered a better alternative to UW to ameliorate the outcome of heart transplantation. 相似文献
95.
Shibasaki S Yamashita K Goto R Oura T Wakayama K Hirokata G Shibata T Igarashi R Haga S Ozaki M Todo S 《Transplant immunology》2012,26(1):42-49
NK026680 is a triazolopyrimidine derivative that has been shown to inhibit dendritic cell maturation and activation. Here, we examined the immunosuppressive properties of NK026680 on T-cell function and assessed its immunosuppressive efficacy in an ACI (RT1av1 haplotype) to Lewis (RT1l) rat heart transplantation model. The effects of NK026680 on T-cell proliferation, activation, and cytokine production were investigated in vitro. Heart transplant recipient rats were administered NK026680 daily for 14 days post-transplantation. In addition to graft survival time, alloimmune responses and graft histology at 4-10 days post-transplantation were assessed. NK026680 was found to inhibit proliferation, CD25 upregulation, IL-2 production, and cell cycle progression in αCD3/αCD28-stimulated murine T cells. These effects were likely due to suppression of the p38 mitogen-activated protein kinase pathway and the subsequent inhibition of p65, c-Fos, and to a lesser extent, c-Jun. Daily NK026680 treatment suppressed alloimmune responses, prevented cellular infiltration into allografts, and prolonged graft survival. The anti-rejection effects of NK026680 were enhanced by tacrolimus. In conclusion, NK026680 inhibits the activation of T cells and prolongs cardiac allograft survival in rats. These features make it a potential candidate immunosuppressant for the treatment of organ transplant patients in the future. 相似文献
96.
Hirokuni Kitamei Kenichi Namba Nobuyoshi Kitaichi Akiko Wakayama Shigeaki Ohno Susumu Ishida 《Case reports in ophthalmology》2012,3(2):180-184
Background
Chickenpox is rarely associated with posterior segment inflammation. We report on a case of unilateral chickenpox chorioretinitis with retinal exudates and periphlebitis.Case Presentation
A 21-year-old healthy man, who suffered from chickenpox 2 weeks prior to symptom development, exhibited mild anterior chamber cells, vitreous opacity, sheathing of retinal veins, and yellow-white exudates in his right eye. Varicella zoster virus DNA was detected by polymerase chain reaction in the aqueous humor. He was treated with intravenous acyclovir followed by oral prednisolone and valaciclovir. Aqueous cells quickly disappeared and retinal exudates diminished within 1 month, leaving faint retinal scarring. Retinal arteritis had never been observed in this patient.Conclusions
Although the ocular findings in this case were similar to acute retinal necrosis (ARN), the clinical features differed from ARN in the following points: (1) mild anterior chamber inflammation, (2) absence of retinal arteritis, and (3) prompt resolution of inflammatory findings. The distinctive clinical features indicated that chorioretinitis associated with chickenpox may not have the same pathological conditions as ARN.Key Words: Chickenpox, Chorioretinitis, Intraocular inflammation, Primary VZV infection, Uveitis, Varicella zoster virus, Acute retinal necrosis 相似文献97.
98.
99.
Ohara A Kojima S Okamura J Inada H Kigasawa H Hibi S Tsukimoto I;Aplastic Anaemia Committee of the Japanese Society of Pediatric Haematology 《British journal of haematology》2002,116(1):151-154
In hepatitis-associated aplastic anaemia (HAA), an immune-mediated mechanism is solely responsible for the development of pancytopenia. We retrospectively analysed the clinical outcome of 61 children with HAA, diagnosed between 1988 and 1996. Of 61 patients, 41 did not receive bone marrow transplantation (BMT) and their survival rate at 7 years was 61.4 +/- 9.3%(+/- SE). Five of these 41 patients developed myelodysplastic syndrome (MDS) or acute myelogenous leukaemia (AML) 7-57 months after the diagnosis of HAA. The incidence of MDS/AML in severe HAA patients who did not receive BMT (n = 30, 27.0 +/- 10.8%) appeared to be similar to that of severe idiopathic AA patients (n = 155, 14.7 +/- 3.7%) treated in the same period. 相似文献
100.